• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 E 基因型披露及阿尔茨海默病风险教育简化方案的效果。

Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.

机构信息

Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

出版信息

Genet Med. 2012 Aug;14(8):742-8. doi: 10.1038/gim.2012.37. Epub 2012 Apr 12.

DOI:10.1038/gim.2012.37
PMID:22498844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3718049/
Abstract

PURPOSE

Brief, effective models of patient genetic education are needed for common, complex diseases. Using Alzheimer disease as a model, we compared participants' risk knowledge and recall in extended versus condensed education protocols.

METHODS

A four-site randomized clinical trial enrolled 280 first-degree relatives of individuals with Alzheimer disease (mean age = 58 years, 71% female); each received lifetime Alzheimer disease risk information (range: 13-74%) that incorporated apolipoprotein E genotype. In the condensed protocol, participants received an educational brochure in place of an in-person education session. Outcomes were assessed at 6 weeks and 6 months following risk disclosure.

RESULTS

The condensed protocol required less clinician time than the extended protocol (mean = 34 min vs. 77 min). The groups did not differ on recall of apolipoprotein E genotype or lifetime risk, and most participants in both groups recalled and retained this information over time. Both groups showed improvement from baseline in Alzheimer disease risk knowledge (e.g., understanding the magnitude of apolipoprotein E genotype effect on risk).

CONCLUSION

A condensed protocol for communicating genetic risk for Alzheimer disease achieved similar educational results as an extended protocol in this study. Further research should explore the efficacy of brief genetic education protocols for complex diseases in diverse populations.

摘要

目的

需要针对常见的复杂疾病制定简短有效的患者遗传教育模型。以阿尔茨海默病为例,我们比较了扩展和浓缩教育方案中参与者的风险知识和回忆能力。

方法

一项四项随机临床试验招募了 280 名阿尔茨海默病患者的一级亲属(平均年龄=58 岁,71%为女性);每位参与者都接受了包含载脂蛋白 E 基因型的阿尔茨海默病终身风险信息(范围:13-74%)。在浓缩方案中,参与者收到了教育手册,而不是面对面的教育课程。在风险披露后的 6 周和 6 个月评估结果。

结果

浓缩方案比扩展方案需要更少的临床医生时间(平均=34 分钟对 77 分钟)。两组在载脂蛋白 E 基因型或终身风险的回忆方面没有差异,并且大多数参与者在两组中都随着时间的推移回忆和保留了这些信息。两组在阿尔茨海默病风险知识方面均较基线有所提高(例如,理解载脂蛋白 E 基因型对风险的影响程度)。

结论

本研究中,传达阿尔茨海默病遗传风险的浓缩方案与扩展方案取得了相似的教育效果。进一步的研究应该探索针对复杂疾病的简短遗传教育方案在不同人群中的效果。

相似文献

1
Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.载脂蛋白 E 基因型披露及阿尔茨海默病风险教育简化方案的效果。
Genet Med. 2012 Aug;14(8):742-8. doi: 10.1038/gim.2012.37. Epub 2012 Apr 12.
2
A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.一项关于阿尔茨海默病遗传风险披露简化方案的随机非劣效性试验。
Alzheimers Dement. 2015 Oct;11(10):1222-30. doi: 10.1016/j.jalz.2014.10.014. Epub 2014 Dec 9.
3
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.载脂蛋白E基因分型披露与阿尔茨海默病终生风险评估的回顾:REVEAL研究
Genet Med. 2006 Dec;8(12):746-51. doi: 10.1097/01.gim.0000250197.44245.a3.
4
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.在阿尔茨海默病基因风险评估中揭示多效性效应:一项随机试验。
Ann Intern Med. 2016 Feb 2;164(3):155-63. doi: 10.7326/M15-0187. Epub 2016 Jan 26.
5
Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.阿尔茨海默病遗传风险评估后的健康行为变化:REVEAL研究。
Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):94-7. doi: 10.1097/WAD.0b013e31815a9dcc.
6
Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL study.影响不同类型阿尔茨海默病风险个人遗传信息回忆的因素:REVEAL研究
Public Health Genomics. 2015;18(2):78-86. doi: 10.1159/000368888. Epub 2015 Jan 24.
7
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.对认知正常成年人的遗传易感性测试和 AD 痴呆风险披露的兴趣:一项调查研究。
Alzheimers Res Ther. 2024 Jan 2;16(1):1. doi: 10.1186/s13195-023-01364-w.
8
"I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.“我知道你告诉过我,但这是我的想法:”那些能准确回忆起基于遗传风险评估的人对阿尔茨海默病风险的感知。
Genet Med. 2010 Apr;12(4):219-27. doi: 10.1097/GIM.0b013e3181cef9e1.
9
Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.披露披露:与沟通阿尔茨海默病遗传易感性检测结果相关的因素。
J Health Commun. 2009 Dec;14(8):768-84. doi: 10.1080/10810730903295518.
10
Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.载脂蛋白Eε4等位基因与阿尔茨海默病的家族聚集性。
Arch Neurol. 1998 Jun;55(6):810-6. doi: 10.1001/archneur.55.6.810.

引用本文的文献

1
Communicating the risk of dementia: a scoping review.痴呆症风险的沟通:一项范围综述
BMJ Neurol Open. 2025 Jul 22;7(2):e001138. doi: 10.1136/bmjno-2025-001138. eCollection 2025.
2
Return of research results across the Alzheimer's Disease Research Centers network.阿尔茨海默病研究中心网络的研究结果反馈
Alzheimers Dement. 2025 Jun;21(6):e70418. doi: 10.1002/alz.70418.
3
Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal.使用大规模或全基因组测序进行基因组研究的结果回报:迈向新常态。
Annu Rev Genomics Hum Genet. 2023 Aug 25;24:393-414. doi: 10.1146/annurev-genom-101122-103209. Epub 2023 Mar 13.
4
Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants.溢出效应:阿尔茨海默病痴呆症新药的批准将影响无症状研究参与者的生物标志物披露。
J Alzheimers Dis. 2022;90(3):1035-1043. doi: 10.3233/JAD-220113.
5
Implementation matters: How patient experiences differ when genetic counseling accompanies the return of genetic variants of uncertain significance.实施情况很重要:当遗传咨询伴随不确定意义的遗传变异结果返回时,患者体验有何不同。
AMIA Annu Symp Proc. 2022 Feb 21;2021:950-958. eCollection 2021.
6
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.超越披露:临床前阿尔茨海默病生物标志物检测中的护理阶段。
Alzheimers Dement. 2022 Oct;18(10):1969-1979. doi: 10.1002/alz.12620. Epub 2022 Feb 25.
7
Young people's moral attitudes and motivations towards direct-to-consumer genetic testing for inherited risk of Alzheimer disease.年轻人对阿尔茨海默病遗传风险直接面向消费者的基因检测的道德态度和动机。
Eur J Med Genet. 2021 Jun;64(6):104180. doi: 10.1016/j.ejmg.2021.104180. Epub 2021 Mar 26.
8
Alzheimer's Prevention Initiative Generation Program: Development of an genetic counseling and disclosure process in the context of clinical trials.阿尔茨海默病预防计划一代项目:在临床试验背景下制定遗传咨询与信息披露流程。
Alzheimers Dement (N Y). 2019 Nov 6;5:705-716. doi: 10.1016/j.trci.2019.09.013. eCollection 2019.
9
Assessing the Psychological Impact of Genetic Susceptibility Testing.评估基因易感性检测的心理影响。
Hastings Cent Rep. 2019 May;49 Suppl 1(Suppl 1):S38-S43. doi: 10.1002/hast.1015.
10
A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.一项通过电话披露阿尔茨海默病遗传风险信息的随机对照试验。
Genet Med. 2018 Jan;20(1):132-141. doi: 10.1038/gim.2017.103. Epub 2017 Jul 20.

本文引用的文献

1
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD001431. doi: 10.1002/14651858.CD001431.pub3.
2
Interventions for individuals with low health literacy: a systematic review.健康素养低的个体干预措施:系统评价。
J Health Commun. 2011;16 Suppl 3:30-54. doi: 10.1080/10810730.2011.604391.
3
Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者心理社会电话咨询干预的随机对照试验。
Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):648-54. doi: 10.1158/1055-9965.EPI-09-0548. Epub 2010 Mar 3.
4
A systematic review of the impact of genetic counseling on risk perception accuracy.一项关于遗传咨询对风险认知准确性影响的系统综述。
J Genet Couns. 2009 Jun;18(3):217-28. doi: 10.1007/s10897-008-9210-z. Epub 2009 Mar 17.
5
Putting science over supposition in the arena of personalized genomics.在个性化基因组学领域,将科学置于臆测之上。
Nat Genet. 2008 Aug;40(8):939-42. doi: 10.1038/ng0808-939.
6
Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.针对接受BRCA1和BRCA2检测的高危女性的电话遗传咨询:随机对照试验的基本原理与开展
Genet Test. 2008 Mar;12(1):37-52. doi: 10.1089/gte.2006.0525.
7
Genomic profiles for disease risk: predictive or premature?疾病风险的基因组图谱:是预测性的还是为时过早?
JAMA. 2008 Mar 19;299(11):1353-5. doi: 10.1001/jama.299.11.1353.
8
Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.将种族因素纳入阿尔茨海默病的遗传风险评估:REVEAL研究经验
Genet Med. 2008 Mar;10(3):207-14. doi: 10.1097/GIM.0b013e318164e4cf.
9
Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.阿尔茨海默病遗传风险评估后的健康行为变化:REVEAL研究。
Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):94-7. doi: 10.1097/WAD.0b013e31815a9dcc.
10
Letting the genome out of the bottle--will we get our wish?让基因组从瓶中释放——我们会如愿以偿吗?
N Engl J Med. 2008 Jan 10;358(2):105-7. doi: 10.1056/NEJMp0708162.